Sotera Health Announces Third-Quarter 2023 Earnings Release Date
18 Outubro 2023 - 8:00AM
Sotera Health Company (Nasdaq: SHC), a leading global provider of
mission-critical end-to-end sterilization solutions and lab testing
and advisory services for the healthcare industry, today announced
its plans to release its financial results for the third-quarter
ended September 30, 2023 before the market opens on Wednesday,
November 1, 2023. Following the release, management will hold a
conference call at 9:00 a.m. Eastern Time to discuss the Company’s
operating highlights and financial results.
To participate in the live call, please dial 1-844-481-2916 if
dialing-in from the United States, or 1-412- 317-0709 if dialing-in
from other locations. A live webcast of the conference call can be
accessed at this link or via the Investor Relations section of
the Company’s website at Presentation & Events | Sotera Health,
along with the accompanying materials. A replay of the webcast will
be available later in the day on November 1st.
Updates can be found from time to time on recent developments in
matters relevant to investors on the Investor Relations section of
the Company’s website at Investor Relations | Sotera Health. For
developments related to Ethylene Oxide, updates can be found at
Ethylene Oxide | Sotera Health.
About Sotera
Health
Sotera Health Company is a leading global
provider of mission-critical end-to-end sterilization solutions and
lab testing and advisory services for the healthcare industry.
Sotera Health goes to market through three businesses –
Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed
to its mission, Safeguarding Global Health®.
Contacts
Jason PetersonVice President & Treasurer,
Sotera Health IR@soterahealth.com
Kristin GibbsChief Marketing Officer, Sotera
Health kgibbs@soterahealth.com
Source: Sotera Health Company
Sotera Health (NASDAQ:SHC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Sotera Health (NASDAQ:SHC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024